Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod

Abstract

Background: Previous reports of cutaneous neoplastic lesions secondary to Fingolimod treatment among multiple sclerosis patients.

Objective: Reporting a case of cutaneous large cell lymphoma in a multiple sclerosis patient during Fingolimod treatment.

Method: Case study.

Result: Our patient developed CD30+ cutaneous large cell lymphoma two years after initiation of Fingolimod treatment and her symptoms regressed following the cessation of treatment.

Conclusion: This report indicates that cutaneous lymphoid neoplasms should be considered a possible side effect among patients receiving Fingolimod.

Keywords: Cutaneous large cell lymphoma; Fingolimod; Multiple sclerosis; Side effect.